Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pro and contra IBR-eradication.

Mathias Ackermann1, Monika Engels

  • 1Institute of Virology, Vetsuisse Faculty, University of Zurich, Winterthurerstrasse 266a, CH-8057 Zurich, Switzerland.

Veterinary Microbiology
|December 13, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Epidemiological, serological, and viral genomic analysis of an outbreak of elephant hemorrhagic disease in Switzerland.

PloS one·2025
Same author

Antibody reactions of horses against various domains of the EHV-1 receptor-binding protein gD1.

PloS one·2024
Same author

Establishment of a Three-Dimensional In Vitro Model of Equine Papillomavirus Type 2 Infection.

Viruses·2021
Same author

Viral infections shared between water buffaloes and small ruminants in Switzerland.

Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc·2021
Same author

Mammalian orthoreovirus core protein μ2 reorganizes host microtubule-organizing center components.

Virology·2020
Same author

Mathias Ackermann and Jean-Michel Hatt respond.

The Veterinary record·2020
Same journal

A divalent nanoparticle vaccine confers robust protective immunity against serotype O FMDV and SVA in pigs.

Veterinary microbiology·2026
Same journal

A Lactobacillus plantarum vaccine candidate with dendritic cell targeting and lysosome escape properities provides efficient protection against necrotic enteritis in broiler chickens.

Veterinary microbiology·2026
Same journal

Tracheal transcriptional response to challenge with virulent Mycoplasma gallisepticum in chickens spray vaccinated with the Vaxsafe MG304 live-attenuated vaccine.

Veterinary microbiology·2026
Same journal

Intermittent shedding dynamics of EHV-1 across biological matrices during a natural outbreak linked to international equestrian events.

Veterinary microbiology·2026
Same journal

Development of a replication-restricted, esterase-deficient influenza D virus as a live vaccine candidate.

Veterinary microbiology·2026
Same journal

Co-infection with CAV facilitates ALV-K replication and induces severe immunosuppression in chickens.

Veterinary microbiology·2026
See all related articles

Eradicating Bovine herpesvirus type 1 (BoHV-1), the cause of infectious rhinotracheitis (IBR), is achievable but challenging. Success requires detecting carriers and improving diagnostic tools, vaccines, and viral characterization methods.

Area of Science:

  • Veterinary Virology
  • Infectious Disease Control

Background:

  • Bovine herpesvirus type 1 (BoHV-1) causes significant respiratory and reproductive diseases in cattle, including infectious rhinotracheitis (IBR).
  • Despite strong immune responses, BoHV-1 establishes lifelong latency, leading to recurrent infections and posing challenges for eradication.
  • Several European countries have pursued IBR eradication, with varying degrees of success, highlighting the complexities involved.

Purpose of the Study:

  • To review the arguments for and against the eradication of BoHV-1 infections in Europe.
  • To assess the feasibility and challenges associated with achieving IBR-free status.
  • To identify areas for improvement in control strategies, diagnostics, and vaccines.

Main Methods:

  • Literature review and analysis of existing BoHV-1 control and eradication programs in Europe.

Related Experiment Videos

  • Discussion of the implications of virus latency and reactivation on eradication efforts.
  • Evaluation of current diagnostic tools, vaccines, and viral characterization methods.

    • Main Results:

    • IBR eradication is achievable, as demonstrated by some European countries, but necessitates rigorous detection and removal of asymptomatic carriers.
    • Current vaccines offer only temporary and limited protection, and their use in eradication programs is constrained.
    • Significant challenges include high costs, considerable risks, and limitations in the quality and effectiveness of available diagnostic and control tools.

    Conclusions:

    • Achieving BoHV-1 eradication requires a comprehensive strategy that includes improved diagnostic sensitivity, more effective vaccines, and better viral characterization.
    • Enhanced collaborative efforts, such as creating a centralized viral strain library, are crucial for advancing eradication initiatives.
    • Further development of superior vaccines and companion diagnostic tests is essential for successful control and eventual eradication of IBR.